Safety and Effectiveness of Letermovir in Allogenic Hematopoietic Stem Cell Transplantation Recipients: Interim Report of Post-marketing Surveillance in Japan

OBJECTIVE: Since May 2018, a 6-year post‑marketing surveillance (PMS) has been underway to evaluate the safety and effectiveness of letermovir for cytomegalovirus (CMV) prophylaxis in Japanese patients with allogenic hematopoietic stem-cell transplantation (allo-HSCT). The interim PMS data for 461 p...

Descripción completa

Detalles Bibliográficos
Autores principales: Hiraishi, Itaru, Ueno, Rie, Watanabe, Asuka, Maekawa, Shinichiroh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626406/
https://www.ncbi.nlm.nih.gov/pubmed/34784011
http://dx.doi.org/10.1007/s40261-021-01096-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626406/
https://www.ncbi.nlm.nih.gov/pubmed/34784011
http://dx.doi.org/10.1007/s40261-021-01096-5

Ejemplares similares